Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 189
Selected: 0
NCT IDTitle
NCT02372877Evaluation of the AMICUS RBCx System in Sickle Cell Patients
NCT02470559Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or Recurrent
NCT00521261Donor T Cells, Low-Dose Aldesleukin, and Low-Dose GM-CSF After Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT00244933Gemcitabine Hydrochloride and Genistein in Treating Women With Stage IV Breast Cancer
NCT00030420Celecoxib and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer
NCT00244946Combination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treating Patients With Non-Hodgkin's Lymphoma
NCT00482846Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple Myeloma
NCT01051570Carboplatin, Everolimus, and Prednisone in Treating Patients With Metastatic Prostate Cancer That Progressed After Docetaxel
NCT00020722Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Women With Stage IV Breast Cancer
NCT07227831A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer
NCT00258245Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia
NCT00459121Vandetanib, Carboplatin, and Paclitaxel in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed by Surgery
NCT06339827ASk Questions in GYnecologic Oncology (ASQ-GYO)
NCT00499694Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel
NCT00217581Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction Cancer
NCT00004022Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma
NCT07343297Ask Questions About Clinical Trials
NCT00918762Transoral Robotic Surgery or Standard Surgery in Treating Patients With Benign or Malignant Tumors of the Larynx and Pharynx
NCT02663622Phase II Trial of Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft-Versus-Host Disease (GVHD) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-002)
NCT00514215Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer
NCT01534143High Dose Busulfan and Bortezomib in Treating Patients With High Risk Multiple Myeloma Undergoing Stem Cell Transplant
NCT00004024Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma
NCT00258310Ph II Long Term/Low Dose Xeloda in Head and Neck Squamous Cell Carcinoma After Surgery, Radiation & or Chemo
NCT03091257A Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple Myeloma
NCT03421652Nivolumab and RT in Treating Patients With Localized/Locally Advanced Urothelial Bladder Cancer Ineligible for Chemo
NCT07218432A Study of the TheraBionic P1 Device in Breast Cancer
NCT00120029Peer Counseling for Weight Loss
NCT06420167DapagliFLOzin in Renal AL Amyloidosis (FLORAL)
NCT01698658Ultrasound Tomography Using SoftVue in Diagnosing Women With Breast Cancer
NCT03683420Music in Reducing Distress in Participants with Cancer During Chemotherapy Treatment
NCT00303901Cryotherapy in Treating Patients With Primary Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery
NCT00369109Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors
NCT02269267The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study)
NCT00002547Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome
NCT00016185Flavopiridol and Docetaxel in Treating Patients With Advanced Solid Tumors
NCT03147885Selinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin Lymphoma
NCT01147016Targeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or III Breast Cancer Undergoing Surgery
NCT02723604Low-Level Laser Therapy for Prevention of Oral Mucositis
NCT00258284Capecitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer
NCT00002907Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma
NCT03252600Lenalidomide, Dexamethasone, and Elotuzumab With or Without Cyclophosphamide in Treating Patients With Relapsed Primary Amyloidosis
NCT00004144Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer
NCT04037462Induction of Sensecence Using Dexamethasone to Re-sensitize NSCLC to Anti-PD1 Therapy
NCT00078923Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate
NCT03033914A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL)
NCT01251952Dose Escalation Trial of Denileukin Diftitox (Ontak) Post Autologous Transplantation
NCT03406858Pembro and HER2Bi-Armed Activated T Cells in Treating Patients With Metastatic Castration Resistant Prostate Cancer
NCT02359019MK-3475 as Maintenance Therapy in Extensive Stage SCLC
NCT03657511Tobacco Cessation Intervention
NCT07130903Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer